MyAmyloidosisTeam

Diflunisal is used off-label to treat wild-type ATTR amyloidosis. While not officially FDA-approved for amyloidosis, doctors may prescribe it because it helps prevent TTR proteins from folding improperly, which can slow disease progression. Studies have shown that diflunisal, along with other medications like tafamidis, may Show Full Answer

Diflunisal is used off-label to treat wild-type ATTR amyloidosis. While not officially FDA-approved for amyloidosis, doctors may prescribe it because it helps prevent TTR proteins from folding improperly, which can slow disease progression. Studies have shown that diflunisal, along with other medications like tafamidis, may help improve survival rates in people with wild-type amyloidosis. It's often prescribed as part of a comprehensive treatment plan that may include other medications to manage specific symptoms.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Wild-Type Amyloidosis — An Overview

What Is ATTR-PN? 6 Facts To Know